A detailed history of Sei Investments CO transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Sei Investments CO holds 10,196 shares of ARCT stock, worth $223,598. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,196
Previous 8,704 17.14%
Holding current value
$223,598
Previous $274,000 25.55%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 07, 2024

BUY
$31.23 - $42.99 $46,595 - $64,141
1,492 Added 17.14%
10,196 $344,000
Q4 2023

Feb 14, 2024

BUY
$17.71 - $32.97 $154,147 - $286,970
8,704 New
8,704 $274,000
Q2 2021

Aug 06, 2021

SELL
$25.79 - $42.11 $134,778 - $220,066
-5,226 Closed
0 $0
Q4 2020

Feb 08, 2021

BUY
$34.61 - $123.66 $180,871 - $646,247
5,226 New
5,226 $222,000

Others Institutions Holding ARCT

About Arcturus Therapeutics Holdings Inc.


  • Ticker ARCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,576,400
  • Market Cap $583M
  • Description
  • Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...
More about ARCT
Track This Portfolio

Track Sei Investments CO Portfolio

Follow Sei Investments CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

News

Stay updated on Sei Investments CO with notifications on news.